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A B S T R A C T
Polycystic ovary syndrome (PCOS) is a common endocrine condition affecting women of reproductive age. There are
many typical signs and symptoms that allow for the diagnosis of PCOS depending on the criteria used. Interestingly,
ethnicity influences the extent of these signs and symptoms; therefore, the frequency of symptoms varies between different
countries and ethnic groups. The prevalence of this syndrome in Croatia is unknown, and it’s clinical and biochemical
characteristics have not yet been reported. During this study, we used the Rotterdam criteria to evaluate 365 Croatian
women with PCOS, and compared them to 304 age matched controls to assess the clinical and biochemical abnormalities
that occur in PCOS patients. The mean age of PCOS patients at presentation was 26.1±5.9 years and of controls were
28.0±4.2 years. Women with PCOS has significantly higher body mass index (BMI) than the control group, although in
both groups most patients had normal weight (76.2% vs. 87.8%). Abdominal distribution of fat tissue was similar in both
groups. Menstrual cycle abnormalities were observed in 90.7% of PCOS patients, and ultrasonographic appearance of
polycystic ovaries was reported in 97.3% of PCOS cases. Nearly 75% of patients with PCOS had hirsutism and 49.6%
had acne. We recorded significantly higher serum levels of luteinizing hormone (LH), total testosterone (TT), free testos-
terone (fT) and insulin, while the serum levels of sex hormone binding globuline (SHBG) and follicular stimulating hor-
mone (FSH) were significantly lower than in the control group. Serum glucose values were not significantly different be-
tween the groups. In conclusion, chronic anovulation, hirsutism and ultrasound appearance of polycystic ovaries are the
dominant features of PCOS in Croatian population. The majority of patients with PCOS had normal body weight. The
incidence of insulin resistance in this group of patients is less than the previously described frequency in other popula-
tions of patients with PCOS and normal weight.
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Introduction
Polycystic ovary syndrome (PCOS) is one of the most
common endocrine disorders in women of reproductive
age. PCOS manifests itself with an array of clinical fea-
tures and symptoms, the three most common being: dis-
orders of ovulation, excessive production of androgens,
and polycystic ovaries on ultrasound. PCOS is often asso-
ciated with obesity and insulin resistance. For a number
of years PCOS has been associated with skin and repro-
ductive manifestations. However, this syndrome became
very interesting to the medical community in the 1980’s,
when it was found that women with PCOS have a higher
risk of obesity, insulin resistance, glucose intolerance,
type 2 diabetes mellitus, dyslipidemia, hypertension, and
metabolic syndrome1. The etiology of the syndrome is
still unclear, however the existence of characteristic mo-
des of inheritance within the family members, favors the
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theory that the syndrome is genetically determined2–4.
The high prevalence and the great diversity of pheno-
types is probably a result of the influence of environmen-
tal and genetic factor, including a small number of key
genes involved in androgen biosynthesis, insulin genes,
and proinflammatory genes. Until recently, there was no
universally accepted clinical definition for PCOS. The
2003 Rotterdam ESHRE/ASRM-sponsored PCOS con-
sensus workshop group concluded that two out of three
criteria have to be met to fit the definition: chronic
anovulation, clinical and/or biochemical hyperandroge-
nism, and polycystic ovaries, and after the exclusion of
diseases that mimic PCOS5. Ovulation disorders usually
become apparent in the form of oligomenorrhea, although
about 20–30% of women with PCOS with oligomenorr-
hea have eumenorrhea (subclinical oligomenorrhea). Ex-
cessive production of androgens or hyperandrogenism
(HA) is confirmed via laboratory analysis, characterized
by elevated values of circulating androgens, or on the ba-
sis of clinical signs, primarily in the form of hirsutism. In
20–40% of women with hirsutism and polycystic ovaries,
analysis of androgens in the serum fails to demonstrate
elevated levels of these hormones. The reason is that the
present available methods of measurement of serum an-
drogens are not sufficiently reliable, or the lack of clear
boundaries of normal values in the circulation of women.
It is considered that normal circulating androgens in the
presence of other clinical signs, does not exclude the di-
agnosis of PCOS. In the past, polycystic ovaries were de-
termined on the basis of histopathological analysis, how-
ever, today evidence of polycystic ovaries on an ultrasound
examination is sufficient. As PCOS is also a functional
disorder of unknown etiology, the diagnosis is based on
exclusion of diseases that manifests similarly. Diseases
that mimic PCOS with increased androgens and ovula-
tion disorders include: non-classic congenital adrenal hy-
perplasia (NCAH), tumors of the ovary and adrenal
glands that secrete androgens, disorders of the adrenal
cortex (e.g. Cushing’s disease), and use of androgen or
anabolic drugs. Endocrine disorders such as hyperpro-
lactinemia and hypo-and hyperthyroidism should also be
excluded in the work-up. The ethnicity of patients influ-
ences the extent of this signs and symptoms, especially
with regard to hirsutism and obesity6. Therefore, the fre-
quency of symptoms varies between different countries
and ethnic groups. The prevalence of this syndrome in
Croatia is unknown, and it’s clinical and biochemical
characteristics have not been reported so far.
Subjects and Methods
Subjects
The examined group included 365 women aged 26.1
±5.9 years, whom had the diagnosis of PCOS according
to the Rotterdam ESHRE/ASRM criteria5: 1) oligo- or
anovulation, 2) clinical and/or biochemical signs of hy-
perandrogenism, and 3) polycystic ovaries on ultrasound
(PCO). Oligo- or anovulation was determined according
to menstrual cycle disturbances as: a) normal menstrua-
tion (menstrual interval of 21 to 35 days with normal
progesterone levels >22.5 nmol/L on 21–24 day of the cy-
cle, determined in two consecutive menstrual cycles; b)
oligomenorrhea (an intermenstrual interval of 36 day-6
months) c) amenorrhea (an intermenstrual interval of 6
months or longer). Hyperandrogenism was evaluated on
the basis of present hirsutism, and/or by elevated andro-
gens (total testosterone (TT), free testosterone (fT), an-
drostenedione (A) and dehidroepiandrosteron sulphate
(DHEAS)). We defined hirsutism based a Ferriman-Gall-
wey index score (FG) of greater than 8, which were fur-
ther divided into three categories: mild (FG 8–9), moder-
ate (FG 10–14), and severe (FG>15)7. Severity of acne
was divided into three groups: mild (acne comedonica),
moderate (acne papulopustulosa), and severe (acne con-
globata)8. Trans-vaginal ultrasound scanning (USS) was
performed by only one expert ultrasonographer to avoid
subjective influence on interpreting the results. PCO was
defined as the presence of 12 or more follicles measuring
2–9 mm in diameter in each ovary and/or ovarian volume
>10 mL. Other possible causes of the symptoms such as
non-classical congenital adrenal hyperplasia (NCAH),
androgen-secreting tumors, hyperprolactinemia, thyroid
gland disturbances and Cushing’s syndrome were ex-
cluded. If the patient met two of these criteria; she was
included in the study after other etiologies were ruled
out. In the control group, we included 304 women, aged
28.0±4.2 years, which were undergoing IVF treatment
due to male infertility. This group included women who
had no disorders of the menstrual cycle, without clinical
biochemical signs of HA, and without ultrasound find-
ings of polycystic ovaries. None of the patients in the con-
trol group had a hormonal disorder, autoimmune disease
or a previous history of gynecological surgery. Prior to
entrance into the study, each participant signed a con-
sent form, had her Body Mass Index (BMI), and waist to
hip ratio (WHR) calculated. Obesity and overweight were
defined according to WHO criteria as a BMI ³30 kg/m2
and ³25 kg/m2 respectively. According to WHO STEPS,
abdominal obesity is defined as a waist-hip ratio above
0.85 for females. All the patients were included in the
study after a regular examination in the Division of Hu-
man Reproduction and Gynecologic Endocrinology of the
Department of Obstetrics and Gynecology, University
Medical Centre Zagreb, Croatia, during the period from
October 2007 to June 2011. Any medications known to
affect sex hormones were discontinued at least six months
prior to enrolment. The study protocol was approved by
the University of Zagreb Medical School Ethics Commit-
tee, under the number 04-1116-2006.
Biochemical analysis
Blood samples were withdrawn from all subjects in
the early follicular phase of a spontaneous or progester-
one induced menstrual cycle (day 3–5). The levels of
luteinizing hormone (LH), follicle-stimulating hormone
(FSH), total testosterone (TT), androstenedione, dehidro-
epiandrosterone sulphate (DHEAS), sex hormone bind-
ing globuline (SHBG), glucose and insulin were mea-
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sured in the peripheral blood. Serum levels of LH, FSH,
and total testosterone were measured by an immuno-
diagnostic procedure by VITROS that measures LH-VI-
TROS, FSH-VITROS, and testosterone-VITROS (Ortho
Clinical Diagnostics, Johnson & Johnson, Rochester,
New York, USA). Serum levels of SHBG, DHEAS, and
androstenedione were determined by a chemolumines-
cent immunometrical reaction, SHBG-Immulite, DHEAS-
-Immulite, and androstenedione-Immulite (Siemens
Healthcare Diagnostics Inc., Deerfield, Illinois, USA).
Coefficients of variation within and between the reaction
rates were between 1.5% and 7.9%. The level of glucose
in plasma was determined by an automated reference
method using hexokinase (Siemens Dade Behring, USA),
and serum insulin values were measured with the Immu-
lite procedure as above (Siemens Healthcare Diagnostics
Inc., Deerfield, Illinois, USA). Serum concentrations of
free testosterone were calculated from TT and SHBG as
previously described9 using a web-based calculator
(http://www.issam.ch/freetesto.htm). Insulin sensitivity
calculated HOMA-IR according to the formula: (insulin
(mU/L x glucose (mmol/L)) / 22.5)10. We defined insulin
resistance as HOMA-IR ³2.511. The biochemical analyzes
were performed at the Department of Clinical Biochem-
istry, Zagreb University Hospital Center, University of
Zagreb, School of Medicine, Zagreb, Croatia.
Statistical analysis
The categorical variables were described by percent-
ages, and the continuous as mean ± standard deviation.
We used the independent Student’s t-test to compare the
values of the means between cases and controls. Differ-
ences in categorical characteristics between cases and
controls were assessed using c2-test. All statistical analy-
ses were done using the SPSS for Windows (version 15.0;
SPSS Inc., Chicago, IL, USA). A p-value <0.05 was con-
sidered statistically significant.
Results
Clinical and biochemical characteristics
of patients
Mean age at presentation was 26.1±5.9 years in PCOS
group, and 28.0±4.2 in the control group. With compari-
son of clinical data, we have shown that women with
PCOS had significantly higher BMI’s than the control
group, although in both groups most patients had nor-
mal weight (76.2% vs. 87.8%). Unexpectedly, the waist-
-to-hip ratio was similar between examined groups.
Nearly 73% of patients with PCOS had hirsutism and
49.6% had acne. Oligomenorrhea was noted in 69.2%,
amenorrhea in 21.5%, while 9.3% had normal menses.
Most of the patients had ultrasonographic appearance of
polycystic ovaries (97.3%). These findings were unilat-
eral in three cases. The incidence of varying degrees of
acne and hirsutism, as well as clinical features of PCOS
and controls are listed in Table 1.
As expected, we recorded significantly higher serum
levels of LH, total testosterone (TT), freeT and insulin,
while the serum levels of SHBG and FSH were signifi-
cantly lower than in the control group. Serum glucose
values were not significantly different between the groups.
The results are shown in Table 2.
Elevated serum levels of TT (>2 nmol/L) were found
in 60.8% of PCOS patients, compared to 4.6% in the con-
trol group. Values of other androgens (fT, A, DHEAS)
were significantly elevated compared to the control. In-
sulin resistance (HOMA-IR >2.5) was found in 21.4% of
patients and 3.0% of the control group, as shown in Table 2.
Discussion and Conclusion
In the present study, we evaluated the clinical and
biochemical characteristics of women with polycystic
ovary syndrome in Croatia. To our knowledge this study
is the first report about clinical and biochemical features
of PCOS in Croatia. Clinical evaluation of hyperandro-
genism is subject to numerous criticisms. Assessment of
hirsutism is relatively subjective; not all researchers use
the standardized FG scale, and a large number of pa-
tients undergo esthetical treatments making it difficult
to accurately assess the degree of hirsutism5. In this
study, only one examiner evaluated the degree of hirsu-
tism and acne, therefore avoiding possible research bias.
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TABLE 1
COMPARISON OF CLINICAL CHARACTERISTICS BETWEEN
PCOS PATIENTS AND CONTROL GROUP
PCOS
(N=365)
Control
(N=304)
p value1
age (years) 26.1±5.9 28.0±4.2 <0.001
BMI (kg/m2) 23.8±4.4 22.5±3.4 <0.001
BMI <25 (kg/m2) (%) 76.2 87.8 0.001
WHR 0.78±0.08 0.79±0.07 0.863
Hirsutism (%) 73.2 12.8 <0.001
FG 8–9 (%) 21.8 5.8 <0.001
FG 10–14 (%) 38.1 7.0 <0.001
FG >15 (%) 13.3 0 <0.001
Acne (%) 49.6 18.2 <0.001
Mild (%) 28.1 10.2 <0.001
Moderate (%) 17.6 5.9 <0.001
Severe (%) 3.9 2.1 <0.001
Menstrual Cycle (%)
Normal (%) 9.3 100 <0.001
Oligomenorrhea (%) 69.2 0 <0.001
Amenorrhea (%) 21.5 0 <0.001
US findings of PCO (%) 97.3 0 <0.001
BMI: body mass index; WHR: waist/hip ratio; US: ultrasound,
PCO: polycystic ovaries
1 Students’ t-test was used for continuous and c2-test for cate-
gorical variables
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In our cohort of patients with PCOS, 73.2% had hirsu-
tism, and acne was found in 49.6% of patients, which is
more that other researchers have found12. In a meta-ana-
lysis by Azziz et al., researchers calculated the cumula-
tive incidence of hirsutism to be approximately 60% and
acne 15–25%, in PCOS patients of all racial groups12. A
described higher incidence of hirsutism and acne in our
population of patients with PCOS correlates with studies
that have shown a pronounced hyperandrogenic stigma
that belongs to the Mediterranean ethnicity, in which
Croatians belong13. Values of serum androgens were sig-
nificantly higher in patients with PCOS compared to the
controls. According to literature data, it is estimated that
60–80% of PCOS patients have elevated circulating an-
drogens14. In our cohort of patients with PCOS elevated
TT >3 nmol/L was noted in 27.1%. This value of total
testosterone is the top reference value when using the
manufacture’s recommendations (Ortho Diagnostics,
Johnson & Johnson’s, Rochester, New York, USA). To-
day, more and more emphasis is placed on the problem of
sensitivity and accuracy of determining total testoster-
one in women15. A serum concentration of TT is ten
times lower, and serum concentration of fT is twenty
times lower, in women compared to men9,15. In regards to
this, we deem it necessary to set new limits on the values
of testosterone in the female population. For our re-
search population, elevated testosterone levels were de-
fined in relation to the 95th percentile values for testos-
terone in the control group (2.0 nmol/L for TT, 26 nmol/L
for fT). Sixty percent of patients with PCOS had elevated
levels of TT above 2.0 nmol/L, as well as 73.8% had ele-
vated levels of fT. Our findings are consistent with the
findings of previous studies that have shown elevated
levels of androgens in about 60–80% of patients with
PCOS. Clinically evident changes in menstrual cycle
were present in 90.7% of patients with PCOS in our
study group compared to the previously reported 75% in
studies whose results were summarized in a large meta-
-analysis of Androgen Excess Society (AES)12. One possi-
ble reason for the higher frequency of cycle disturbance
is the fact that our patients with PCOS were recruited at
the gynecology clinic. The main reason for referral to the
clinic was due to cycle disturbances, which probably in-
fluenced our results. Ultrasound findings of polycystic
ovaries were present in almost all of our patients with
PCOS in the study. Only ten patients with PCOS (2.7%)
had normal ultrasound findings, which is much lower
than 25% of patients with PCOS in the already-men-
tioned meta-analysis of AES12. We believe that there is a
limiting factor in the underlying studies included in the
meta-analysis that influenced the huge difference in our
results. In most American studies, ultrasound diagnos-
tics were not performed by doctors but by ultrasound
technicians, who do not possess clinical insight as com-
pared to a physician. The advantage of our research is
the fact that all ultrasound examinations were perfor-
med at one institution, with the same transvaginal ultra-
sound device, and by a physician who strictly kept to the
Rotterdam criteria for the diagnosis of PCOS. Most of
the patients included in this study had normal body
weight in both groups surveyed (76.2% PCOS group vs.
87.8% control group). Values of serum insulin were with-
in in normal limits in both groups of women, however
values were significantly higher in the PCOS patient
group. When we have a group of patients with PCOS and
a BMI of <25 kg/m2, insulin resistance occurs in 16.5% of
the patients, whereas PCOS patients with a BMI equal to
or above 25 kg/m2, 42.3% will show insulin resistance. In-
creased incidence of insulin resistance in a group of
women with a higher BMI may be expected, since it is
considered that the increased body weight triggers a
stronger manifestation of insulin resistance in patients
with PCOS. According to literature, about 80% of pa-
tients with PCOS have an increased body weight, and
35% of patients with PCOS who have a normal body
weight will have insulin resistance16. We studied a popu-
lation of patients with PCOS, in which 21.4% of patients
had insulin resistance, which is consistent with the find-
ings of Gambineri et al., who investigated the presence of
insulin resistance in a Mediterranean population of pa-
tients with PCOS17. The presence of insulin resistance
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TABLE 2
DIFFERENCES BETWEEN CONCENTRATIONS OF VARIOUS
HORMONES AND METABOLITES IN PCOS AND CONTROL
GROUPS
PCOS
(N=365)
Controls
(N=304)
p-value1
FSH (IU/L) 3.9±1.8 5.2±1.5 <0.001
LH (IU/L) 8.9±5.3 3.3±1.2 <0.001
TT (nmol/L) 2.6±0.9 1.2±0.3 <0.001
2TT >2.0 (nmol/L) (%) 60.8 4.6 <0.001
TT >3.0 (nmol/L) (%) 27.1 0 <0.001
fT (pmol/L) 43.9±24.2 14.6±4.3 <0.001
fT >26.0 (pmol/L) (%) 73.8 4.1 <0.001
A (nmol/L) 11.2±4.8 7.7±2.5 <0.001
DHEA-S (mmol/L) 6.7±2.7 5.0±2.0 <0.001
SHBG (nmol/L) 38.9±20.8 59.1±20.1 <0.001
glucose (mmol/L) 4.4±0.6 4.3±0.5 0.901
insulin (mIU/L) 12.1±8.2 6.9±2.4 <0.001
GIR 10.1±6.5 13.3±6.4 <0.001
HOMA-IR 2.4±2.7 1.4±0.6 <0.001
HOMA-IR >2.5 (%) 21.4 3.0 <0.001
HOMA-IR >2.5 and
BMI <25 kg/m2
16.5 3.4 <0.001
HOMA-IR >2.5 and
BMI >25 kg/m2
42.3 0 <0.001
BMI: body mass index; WHR: waist/hip ratio; FSH: follicle stim-
ulating hormone; LH: luteinizing hormone; TT: total testoster-
one; FT: free testosterone; DHEAS: dehydroepiandrosterone
sulphate; SHBG: sex hormone binding globulin; GIR: glucose to
insulin ratio; HOMA-IR: homeostatic model assessment of insu-
lin resistance
1 Student t-test continuous variables and c2-test for categorical
variables; 2 95 percentile for the control group
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was 16.5% of patients with PCOS and BMI <25 kg/m2,
confirms that fact that its cause cannot be interpreted
only by obesity18. SHBG serum levels in patients with
PCOS were significantly lower than values measured in
the control patient group. We have also expected to find
the difference in body composition between PCOS group
and control that may influence the sex hormone levels in
PCOS patients19 but this difference was not observed in
our study. By analyzing the clinical and biochemical
characteristics of our studied population of patients with
PCOS, we can conclude that the majority of our patients
expressed all three diagnostic features of PCOS (hy-
perandrogenism, menstrual abnormalities, and ultra-
sound findings of polycystic ovaries). The majority of pa-
tients with PCOS had a normal body weight. The inci-
dence of insulin resistance in this group of patients with
PCOS is less than the previously described frequency in
other populations of patients with PCOS and normal
weight16,18,20,21.
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KLINI^KE I BIOKEMIJSKE KARAKTERISTIKE BOLESNICA SA SINDROMOM
POLICISTI^NIH JAJNIKA U HRVATSKOJ POPULACIJI
S A @ E T A K
Sindrom policisti~nih jajnika (PCOS) jedan je od naj~e{}ih endokrinolo{kih poreme}aja `ena reprodukcijske dobi.
Prezentira se, ovisno o kriterijima koji se koriste za postavljanje dijagnoze, s mno{tvom tipi~nih znakova i simptoma.
Pojavnost razli~itih znakova i simptoma razlikuje se me|u pojedinim etni~kim skupinama. Prevalencija ovog sindroma
u Hrvatskoj populaciji nije poznata, a njegove klini~ke i biokemijske karakteristike do sada nisu istra`ene. U studiju
smo uklju~ili 365 `ena s PCOS i usporedili ih s 304 zdrave `ene koje su slu`ile kao kontrole. Dijagnozu smo postavili na
temelju Rotterdamskog konsezusa. Prosje~na dob `ena s PCOS iznosila je 26,1±5,9 godinu, a u kontrolnoj skupini
28,0±4,2 godinu. @ene s PCOS imale su zna~ajno vi{i indeks tjelesne mase (ITM) u odnosu na kontrolnu skupinu, iako
je ve~ina `ena uklju~enih u studiju imala normalnu tjelesnu te`inu (76,2% naspram 87,8%). U~estalost abdominalne
debljine bila je jednaka u obje ispitivane skupine. Abnormalnosti menstruacijskog ciklusa na|ene su u 90,7% bolesnica
s PCOS, a tipi~an ultrazvu~ni nalaz policisti~nih jajnika u 97,3% slu~ajeva s PCOS. Gotovo 75% `ena s PCOS imalo je
hirzutizam, a 49,6% njih akne. Kod `ena s PCOS na|ene su zna~ajno vi{e vrijednosti luteiniziraju}eg hormona (LH),
ukupnog testosterone, slobodnog testosterone i inzulina, te sni`ene vrijednosti hormona koji ve`e spolne hormone (SHBG) i
folikulostimuliraju}eg hormona (FSH) u odnosu na kontrolnu skupinu. Vrijednosti glukoze, odre|ene na ta{te, nisu se
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zna~ajno razlikovale me|u ispitivanim skupinama. Zaklju~no, kroni~na anovulacija, hirzutizam i ultrazvu~ni nalaz
policisti~nih jajnika naj~e{}e su zna~ajke PCOS u Hrvatskoj populaciji. Ve}ina `ena s PCOS normalne je tjelesne te`ine.
U~estalost inzulinske rezistencije u `ena s PCOS i normalnom tjelesnom te`inom u Hrvatskoj populaciji zna~ajno je
manja u odnosu na druge etni~ke skupine.
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